Skip to main content
. 2021 May 18;12:665521. doi: 10.3389/fendo.2021.665521

Table 2.

Maximal or minimal activity and EC50 or IC50 of progestins on HG5LN-hPXR and HG5LN-zfPXR.

Compound hPXR agonism zfPXR agonism zfPXR antagonism
EC50 (µM) Max (%) EC50 (µM) Max (%) IC50 (µM) Min (%)
DMSO   19 ± 6   28 ± 1.7    
Chlormadinone acetate n.a. - n.a. - n.a. -
Desogestrel* 4.2 ± 0.2 54 0.13 ± 0.01 99 n.a. -
17α,20β-Dihydroxy-4-pregnen-3-one n.a. - n.a. - n.a. -
Drospirenone 18 ± 1.4 44 n.a. - 3.6 ± 0.4 52
Dydrogesterone n.m. 27 n.a. - n.a. -
Ethisterone n.a. - n.a. - n.a. -
Etynodiol diacetate* n.a. - 0.32 ± 0.02 92 n.a. -
Etonogestrel 24 ± 4.6 27 2.3 ± 0.2 90 n.a. -
Gestodene* n.a. - 0.18 ± 0.01 81 n.a. -
Gestonorone n.a. - n.a. - n.a. -
Levonorgestrel n.a. - 1.4 ± 0.2 74 n.a. -
Lynestrenol* 41 ± 7.7 30 0.23 ± 0.01 98 n.a. -
Medroxyprogesterone 18 ± 2.4 50 n.a. - n.a. -
Megestrol acetate 19 ± 4.3 50 n.a. - n.a. -
Mifepristone* 5.9 ± 0.2 39 n.a. - 0.08 ± 0.003 10
Nestorone n.a. - n.a. - n.a. -
Nomegestrol acetate n.a. - n.a. - n.a. -
Norethisterone n.a. - 2.2 ± 0.4 54 n.a. -
Progesterone 9.1 ± 2.2 72 n.a. - 0.64 ± 0.03 14
Promegestone n.a. - n.a. - n.a. -
Tibolone* n.a. - 0.56 ± 0.04 96 n.a. -

n.a., not active; max, maximal activity of the chemicals obtained at 10 µM except for compounds that were not tested above 3 µM because of toxicity*; min, minimal activity of the chemicals obtained at 10 µM except for compounds that were not tested above 3 µM because of toxicity*.

Maximal activities of the chemicals obtained at 10 µM are expressed as a percentage of the maximal induced by 3 µM SR 12813 and 1 µM clotrimazole for HG5LN-hPXR and HG5LN-zfPXR, respectively. Antagonism assays were performed in coexposure with 0.3 µM SR 12813 in HG5LN-hPXR cells and 0.03 µM clotrimazole in HG5LN-zfPXR cells. Minimal activities of the chemicals obtained at 10 µM are expressed as a percentage of the maximal induced by 3 µM SR 12813 and 1 µM clotrimazole for HG5LN-hPXR and HG5LN-zfPXR, respectively.